Pharmacy

Glynase XL Glucotrol XL

Home » Prescription Drugs 8 » Glynase XL Glucotrol XL

Glipizide is used to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) particularly in people whose diabetes cannot be controlled by diet alone. Glipizide lowers blood sugar by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently. The pancreas must be capable of producing insulin for this medication to work. Glipizide is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood).

Buy Glynase XL Glucotrol XL and other Prescription Drugs 8 products online at Medstore.

Buy Online at Medstore - Click Here!

About Glynase XL Glucotrol XL:

Product Type: Prescription Drugs 8

Glynase XL (Glucotrol XL Generic Glipizide)

Glynase XL (Glucotrol XL Generic Glipizide)

Glucotrol XL Generic Glipizide

10mg 100 Tablets 10mg 200(2 x 100) Tablets 10mg 400(4 x 100) Tablets 5mg 100 Tablets 5mg 200(2 x 100) Tablets 5mg 400(4 x 100) Tablets Glucotrol XL Generic Glipizide Glynase XL

View more Prescription Drugs 8

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.